Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lajos Kemény, Lovisa Berggren, Martin Dossenbach, Yves Dutronc & Carle Paul. (2019) Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3. Journal of Dermatological Treatment 30:1, pages 19-26.
Read now
Read now
Articles from other publishers (29)
Weize Gao, Zhan Wang, Wenshuai Li, Yongxin Li & Mingjun Liu. (2023) Biomarkers and biologics related with psoriasis and psoriatic arthritis. International Immunopharmacology 122, pages 110646.
Crossref
Crossref
Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, Ronald B. Vender, Can Mert, Nithi Tangsirisap, Natalie Haustrup, Gaia Gallo, Christopher Schuster & Patrick M. Brunner. (2023) Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO). Frontiers in Medicine 10.
Crossref
Crossref
I. S. Vladimirova & I. O. Smirnova. (2023) Psoriasis with facial skin lesions that arose against background of withdrawal of ixekizumab (clinical case). Medical alphabet:5, pages 49-52.
Crossref
Crossref
Melinda Gooderham, Kim A. Papp, Charles Lynde, Isabelle Delorme, Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Danielle Brassard, Vimal H. Prajapati, Antonio Vieira & Lenka Rihakova. (2022) Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and Therapy 13:2, pages 535-553.
Crossref
Crossref
Sung Min Kim, Juhee Ahn, Young Ah Cho, Jae Young Sung, Chang Yong Kim, Da‐Ae Yu, Yang Won Lee, Sungho Won & Yong Beom Choe. (2022) Increased risk of suicidality in patients with psoriasis: A Nationwide cohort study in Korea. Journal of the European Academy of Dermatology and Venereology 37:1, pages 75-84.
Crossref
Crossref
Bhupinder Kapoor, Monica Gulati, Pooja Rani & Reena Gupta. (2022) Psoriasis: Interplay between dysbiosis and host immune system. Autoimmunity Reviews 21:11, pages 103169.
Crossref
Crossref
Abdulhadi Jfri, Bonnie Leung, Jordan T Said, Yevgeniy Semenov & Nicole R LeBoeuf. (2022) Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors. Immunotherapy Advances 2:1.
Crossref
Crossref
Angelo Ruggiero, Gabriella Fabbrocini, Sara Cacciapuoti, Eleonora Cinelli, Lucia Gallo & Matteo Megna. (2021) Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis. Journal of Clinical Medicine 10:5, pages 1031.
Crossref
Crossref
M.‐A. Richard, J.‐P. Lacour, M.‐P. Konstantinou, M. Ruer‐Mulard, P. Joly, S. Aractingi, P. Auquier, B. Pelvet, M.L. Augustin, E. Mahé & R.J.G. Chalmers. (2020) Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study. Journal of the European Academy of Dermatology and Venereology 35:3, pages 677-684.
Crossref
Crossref
Cameron M.B. Zachary, Annika Belzer, Nathan P. Fackler, Jessica Shiu, Janellen Smith & Ruby Ghadially. (2021) Facial psoriasis in a mask-like distribution. JAAD Case Reports 7, pages 128-130.
Crossref
Crossref
Kevin K. Wu, Michael P. Lee & Jashin J. Wu. 2019. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis
39
44
.
Clarice Marie Kobata. (2018) Psoríase – visão do dermatologista. Revista Paulista de Reumatologia:2018 out-dez;17(4), pages 6-12.
Crossref
Crossref
Klaudia Dopytalska, Piotr Sobolewski, Agata Błaszczak, Elżbieta Szymańska & Irena Walecka. (2018) Psoriasis in special localizations. Rheumatology 56:6, pages 392-398.
Crossref
Crossref
Joseph F. Merola, Abrar Qureshi & M. Elaine Husni. (2018) Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatologic Therapy 31:3.
Crossref
Crossref
C. Paul, L. Guenther, H. Torii, H. Sofen, R. Burge, C.Y. Lin, A. Potts Bleakman, L. Mallbris & Y. Poulin. (2017)
Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate‐to‐severe psoriasis patients: 12‐week results from two phase
III
trials
. Journal of the European Academy of Dermatology and Venereology 32:1, pages 68-72.
Crossref
Crossref
Mina Amin, Daniel J. No & Jashin J. Wu. 2017. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis
35
40
.
Mina Amin, Daniel J. No & Jashin J. Wu. 2017. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis
29
33
.
April W. Armstrong, Delfina Guadalupe Villanueva Quintero, Cristina M. Echeverría, Yihua Gu, Mahinda Karunaratne & Ofelia Reyes Servín. (2016) Body Region Involvement and Quality of Life in Psoriasis: Analysis of a Randomized Controlled Trial of Adalimumab. American Journal of Clinical Dermatology 17:6, pages 691-699.
Crossref
Crossref
Leon Kircik, Joseph Fowler, Jonathan Weiss, Xiangyi Meng, Adriana Guana & Judit Nyirady. (2016) Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies. Dermatology and Therapy 6:4, pages 627-638.
Crossref
Crossref
Sharifah Rosniza Syed Nong Chek, Suganthy Robinson, Azura Mohd Affandi & Nurakmal Baharum. (2016) Clinical characteristics of patients with facial psoriasis in Malaysia. International Journal of Dermatology 55:10, pages 1092-1095.
Crossref
Crossref
Mossum K. Sawhney & Michael R. Hamblin. 2016. Handbook of Low-Level Laser Therapy. Handbook of Low-Level Laser Therapy
1017
1048
.
Vera Leibovici, Natalya Lemster, Yuval Ramot, Rula Siam, Ihab Siam, Alex Maly, N. Strauss-Liviatan & Malka Hochberg. (2015) Prevalence of interdigital psoriasis of the feet (“psoriasis alba”) in mild, moderate, and severe psoriasis. International Journal of Dermatology 54:9, pages 1084-1087.
Crossref
Crossref
Silje Haukali Omland & Robert Gniadecki. (2015) Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?. Clinics in Dermatology 33:4, pages 456-461.
Crossref
Crossref
Jeffrey M. Cohen, Abrar A. Qureshi & Joseph F. Merola. (2015) A Comprehensive Assessment Tool for Psoriasis — An Unmet Need: Report from the GRAPPA 2014 Annual Meeting. The Journal of Rheumatology 42:6, pages 1032-1033.
Crossref
Crossref
Mital Patel, Stephanie W. Liu, Abrar Qureshi & Joseph F. Merola. (2014) The Brigham Scalp Nail Inverse Palmoplantar Psoriasis Composite Index (B-SNIPI): A Novel Index to Measure All Non-plaque Psoriasis Subsets. The Journal of Rheumatology 41:6, pages 1230-1232.
Crossref
Crossref
Zain U. Syed & Amor Khachemoune. (2011) Inverse Psoriasis. American Journal of Clinical Dermatology 12:2, pages 143-146.
Crossref
Crossref
S Rassai, A Feily, N Sina & A Hajikaramian. (2010) Facial involvement in Iranian psoriatic patients and its relation to severity of the disease. Journal of the European Academy of Dermatology and Venereology 24:12, pages 1488-1489.
Crossref
Crossref
Josep Manel Casanova, Verónica Sanmartín, Xavier Soria, Marta Ferran, Ramon M. Pujol & Miquel Ribera. (2009) Tratamiento tópico de la psoriasis. Piel 24:10, pages 556-567.
Crossref
Crossref
Alison M. Layton. (2009) Dermatological causes of a ‘red face’. Medicine 37:5, pages 249-254.
Crossref
Crossref